GSK to launch 'promecta' in India by 2009-end

Last Updated: Thu, Aug 27, 2009 10:10 hrs

Glaxo SmithKline Pharmaceutical today said it is looking at launching its patented medicine promecta, used in treatment of depleted platelet count, in India by this year-end or early next year.

Most Read
TCS, Infosys, Wipro win a slice of BP outsourcing deal
Top IT security threats downloaded while surfing
Air India chief warns of lay-offs, if crisis continues
Have you got NHPC shares?
Inflation rises, still minus 0.95%
First look: Maruti's new Estilo

"We are looking to launch our promecta in the Indian market in the fourth quarter of this year or in the first quarter of next year," GSK Vice President South Asia and Managing Director India Hasit Joshipura told reporters on the sidelines of a function here.

When asked if the company has got drug regulator DCGI nod for launching the medicine here, he said, "We have applied for the regulatory approval but we haven't got it yet. But we hope to get it by the end of this year of early next year."

More from Sify: